News

LifeLUNG (www.lifelung.eu) is a doctoral training network built around a community of leading European experts in lung transplantation and gene therapy. The network consists of 9 academic and 10 non-academic partners in 11 countries, including Fundació HiTT. LifeLUNG is now recruiting 15 highly motivated doctoral candidates (DCs) willing and excited to go the extra mile.
-> Continue reading LifeLUNG project is recruiting 15 doctoral candidates

Cancer Patients Europe (CPE), the Asociación Española contra el Cáncer and Fundació HiTT are organising a conference on 10 October entitled The new EU HTA regulation and opportunities for patients, which will be held at the Spanish Parliament in Madrid. The aim of the event is to discuss with experts from different fields how the
-> Continue reading The Spanish Congress hosts a conference on the new EU HTA regulation and patients

The project “Analysis of Open Data on Drug Billing Using AI-Based Data Analysis Tools”, coordinated by Mireia Andrés, from UIC Barcelona, and with the participation of Fundació HiTT, has been awarded with a grant in the fisrt call for proposals launched by the UIC’s Observatory of Artificial Intelligence and New Technologies (OIANT). In its evaluation,
-> Continue reading A Fundació HiTT project on drug billing data analysis using AI, funded by the OIANT-UIC call

Respiratory infections are the second leading cause of morbidity and mortality worldwide. In recent years, and especially as a consequence of pandemics, molecular diagnosis has acquired a fundamental role in the etiological identification of these infections. However, in the Spanish context, no consensus has been established on the use of molecular techniques for the diagnosis
-> Continue reading Towards a consensus on the use of molecular techniques in the diagnosis of viral respiratory infections

At the HiTT Foundation, we are carrying out a study to better understand the needs of the health sector in terms of financing and, thus, to contribute to improving it in the future. To do this, we are collecting contributions from different agents in the health system. We invite you to participate by responding to
-> Continue reading What are your financial needs?

Fundació HiTT has launched a survey to gather information and evidence on how to formulate succesful strategies for a meaningful and structured patient involvement in the Health Technology Assessment (HTA) process. While HTA is essential for ensuring that treatments and medical technologies are efficacious, cost-effective and accessible to the public, a truly responsive healthcare system
-> Continue reading Participate in the survey on how to improve patient involvement in HTA

Today, 24 March, is World TB Day. This milestone in the calendar is a reminder, not a celebration. It can in no way be a celebration while tuberculosis remains a major global health issue. In 2023, an estimated 10.8 million people fell ill with TB worldwide, including 6.0 million men, 3.6 million women, and 1.3
-> Continue reading Health technology innovation is still needed to fight tuberculosis

The EU Health Technology Assessment Regulation (HTAR), approved in 2021, will become effective as of 12 January 2025. Its main objectives are to improve and speed up access for European patients to innovative health technologies —including both new medicines and medical devices— and to increase transparency and efficiency of the assessment processes. By establishing a
-> Continue reading Opportunities and challenges of the new EU HTA regulation

The director of the HiTT Foundation, Maria Buxadé, is one of the scientists taking part in the European Commission’s Regional Innovation Valleys call for innovation, which is promoted by ACCIÓ in Catalonia. FHiTT and, in particular, its director, takes part in it as the head of the Dryox Health research project, specialized in detecting unmet
-> Continue reading FHiTT is committed to regional innovation driven by ACCIÓ

With pleasure we have agreed to sign the stakeholder’s recommendations to the EU Commission on the development of the #EHDS (European health Data Space)  Click here to upload EHDS consensus statement

As a follow up from previous activities on #RWD, we are happy to share a paper (https://doi.org/10.3390/healthcare10091629) just released discussing on the potential of the newly proposed #EHDS (European Health Data Space), coordinated by #denishorgan from the #EAPM (European alliance for Personalised Medicine). Interestingly enough, it begins with an ambitious #datagovernance claim to the discuss
-> Continue reading European Health Data Space

We are pleased to announce that Magda Martí has recently joined Fundació HiTT’s team as a managing director. With a solid background in the health field management, she brings to the team over 20 years of management experience in non-profit organisations and in both public and private entities (research centres, foundations and associations for international cooperation and
-> Continue reading Magda Martí joins Fundació HiTT’s team as the Manager Director

Researchers at Fundació HiTT and UOC publish a guide on how to improve patient care while increasing the efficiency and effectiveness of the healthcare system. Multiple sclerosis (MS) is a chronic degenerative autoimmune disease of the central nervous system. Around 1,800 new cases are diagnosed in Spain each year, mostly among people under the age of 40,
-> Continue reading FHiTT and UOC have published a digital transformation support guide applied to multiple sclerosis

The XL+1 edition of the Health Economics Conference, organized by the AES Health Economics Association, has taken place in Zaragoza on June 15 to 17. We have taken part of this event exploring issues such as: medical care decision-making, economic assessment, the management of healthcare institutions and the investment in innovation. Fundació HiTT inaugurated its participation in
-> Continue reading AES – Health Economics Conference

Multiple Sclerosis is a chronic disease that currently affects around 55,000 people in Spain and gathers 1,800 new diagnoses each year. World Multiple Sclerosis Day raises awareness of a complex, cross-cutting disease that involves healthcare, psychological and social issues. Aimed by the twofold goal of meeting the needs of people with Multiple Sclerosis and optimizing
-> Continue reading WORLD MULTIPLE SCLEROSIS DAY

Clinical trials have traditionally been the quintessential clinical research tool, responsible for driving many of the scientific advances made in the field of health and the historical transformations that have taken place in terms of hope and life quality. May 20th, the International Clinical Trial Day, becomes an opportunity to highlight the work of those
-> Continue reading CLINICAL TRIALS DAY

Lung cancer is a growing issue worldwide. It currently ranks as the cancer with the highest number of cases detected, and it is responsible for the highest number of cancer deaths on a global scale. By 2024, it is estimated to be the cause of 3 million new cancers. In Spain, lung cancer is the
-> Continue reading CASSANDRA PROJECT FOR LUNG CANCER EARLY DETECTION

THE PROJECT In collaboration with the Catalan Agency for Health Quality and Assessment (AQuAS), Fundació HiTT carried out a project for the reformulation of the protocol, approved by the Department of Health of Catalonia in 2009, for the correct detection and treatment of women and children victims of gender-based violence. The study aimed to assess
-> Continue reading CASE STUDY: PROJECT AGAINST GENDER VIOLENCE

Fundació HiTT went public on a day like today in 2019. While we were getting closer to days of celebration, we had one more reason to be happy: the birth of the HiTT Foundation. Happiness that today we remember one more time seeing, on its second anniversary, the progress it has made. After years of
-> Continue reading FUNADCIÓ HiTT 2ND ANNIVERSARI